Poor health outcomes in infants with vitamin B 12 deficiency include anemia, abnormal skin and hair development, convulsions, weak muscle tone, failure to thrive, mental developmental delay, and potentially abnormal movements.[4-8] Well-recognized at risk groups are exclusively breastfed infants of mothers with B 12 deficiency due to minimal or no dietary intake of animal products[9-21] or pernicious anemia caused by a maternal malabsorption of B 12 .[18,22] Infant vitamin B 12 status can be improved through maternal B 12 supplementation during pregnancy and lactation.[23-26] Deficient mothers who miss the opportunity to supplement during pregnancy should still be encouraged to supplement during early lactation since infant vitamin B 12 status correlates with milk vitamin B 12 levels in breastfed infants up to 6 months of age.[27-30] Although there are cases reported of exclusively breastfed infants with vitamin B 12 deficiency having biochemical and clinical improvement through adequate maternal supplementation alone,[9] direct supplementation of the infant is recommended when such treatments are available.[31-33] Drug Levels Methylcobalamin is the major form of vitamin B 12 in milk
The latest study shows absorption and immune cell empowerment
Notably, the #14 mutant produced 1.98 g/L of glutathione with a volumetric productivity of 26.36 mg/L/h in the molasses/CSL-based medium, showing efficiency comparable to genetically engineered strains
The real transformation comes from addressing the core metabolic and behavioral drivers of weight gain
Glutathione has been thought to decline as we age, and this deficit is linked to certain health conditions, including cystic fibrosis, diabetes, and Parkinsons
The glutathione inhibits melanin production, reducing the visibility of dark patches, freckles, and blemishes
